Clinical Trial Update: Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating MSI-1436C for metastatic breast cancer has been terminated; the update addresses safety and tolerability but does not report efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• MSI-1436C

Snippet

Sponsor: Northwell Health | Conditions: Metastatic Breast Cancer | Phase 1 | Status: TERMINATED